RxDoctor Payments Data

Larry Parker, MD

Orthopaedic Surgery of the Spine · Huntsville, ALNPI 1770521551

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $86,172 of the $135,609 with a category attached, or 63.5%. Precision Spine, Inc. accounts for 76.9% of it on its own, with 21 other manufacturers making up the rest.

$135,609in general payments, 2019–2025

Across 142 payments — averaging $954.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Precision Spine, Inc.$104K
  • Ulrich Medical USA, Inc.$22K
  • Medtronic$3K
  • Intrinsic Therapeutics$2K
  • Highridge Medical LLC$2K
  • Curiteva, Inc.$934
  • plus $2K from 16 others
$3,209in research payments, 2019–2025

Across 12 payments — averaging $267.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intrinsic Therapeutics$3K
  • Medtronic$209

What the payments were for

  • Royalty or licence$86,17264%
  • Consulting fees$42,68631%
  • Travel & lodging$2,6192%
  • Food & beverage$4,1313%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$135,609 in reported general payments places this provider in the 70th percentile of 20 orthopaedic surgery of the spine providers in Alabama.

See all orthopaedic surgery of the spine providers in Alabama

Medicare billing

Part B allowed, 2024
$475,756
Medicare patients
350
Services billed
1,581

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl267$3,616
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen416$3,376
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen287$3,332
Gabapentin366$2,413
Methylprednisolone261$2,011
Cyclobenzaprine Hcl456$1,632
Tizanidine Hcl100$1,219
Methocarbamol127$925
Diclofenac Sodium16$551
Mupirocin41$374
Pregabalin33$345
Celecoxib15$314
Meloxicam102$296
Tramadol Hcl80$184
Baclofen21$173

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →